Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 53
1.
Proc Natl Acad Sci U S A ; 119(38): e2122523119, 2022 09 20.
Article En | MEDLINE | ID: mdl-36112647

T cell intracellular antigen-1 (TIA-1) plays a central role in stress granule (SG) formation by self-assembly via the prion-like domain (PLD). In the TIA-1 PLD, amino acid mutations associated with neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) or Welander distal myopathy (WDM), have been identified. However, how these mutations affect PLD self-assembly properties has remained elusive. In this study, we uncovered the implicit pathogenic structures caused by the mutations. NMR analysis indicated that the dynamic structures of the PLD are synergistically determined by the physicochemical properties of amino acids in units of five residues. Molecular dynamics simulations and three-dimensional electron crystallography, together with biochemical assays, revealed that the WDM mutation E384K attenuated the sticky properties, whereas the ALS mutations P362L and A381T enhanced the self-assembly by inducing ß-sheet interactions and highly condensed assembly, respectively. These results suggest that the P362L and A381T mutations increase the likelihood of irreversible amyloid fibrillization after phase-separated droplet formation, and this process may lead to pathogenicity.


Amino Acids , Amyotrophic Lateral Sclerosis , Prions , Protein Aggregation, Pathological , T-Cell Intracellular Antigen-1 , Amino Acids/chemistry , Amino Acids/genetics , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/metabolism , Distal Myopathies/genetics , Distal Myopathies/metabolism , Humans , Mutation , Prions/chemistry , Protein Aggregation, Pathological/genetics , Protein Conformation, beta-Strand/genetics , Protein Domains/genetics , T-Cell Intracellular Antigen-1/chemistry , T-Cell Intracellular Antigen-1/genetics
2.
J Biol Chem ; 298(6): 102002, 2022 06.
Article En | MEDLINE | ID: mdl-35504351

P2X receptors are a class of nonselective cation channels widely distributed in the immune and nervous systems, and their dysfunction is a significant cause of tumors, inflammation, leukemia, and immune diseases. P2X7 is a unique member of the P2X receptor family with many properties that differ from other subtypes in terms of primary sequence, the architecture of N- and C-terminals, and channel function. Here, we suggest that the observed lengthened ß2- and ß3-sheets and their linker (loop ß2,3), encoded by redundant sequences, play an indispensable role in the activation of the P2X7 receptor. We show that deletion of this longer structural element leads to the loss of P2X7 function. Furthermore, by combining mutagenesis, chimera construction, surface expression, and protein stability analysis, we found that the deletion of the longer ß2,3-loop affects P2X7 surface expression but, more importantly, that this loop affects channel gating of P2X7. We propose that the longer ß2,3-sheets may have a negative regulatory effect on a loop on the head domain and on the structural element formed by E171 and its surrounding regions. Understanding the role of the unique structure of the P2X7 receptor in the gating process will aid in the development of selective drugs targeting this subtype.


Adenosine Triphosphate , Protein Conformation, beta-Strand , Receptors, Purinergic P2X7 , Adenosine Triphosphate/metabolism , Humans , Inflammation , Protein Conformation, beta-Strand/genetics , Protein Stability , Receptors, Purinergic P2X7/chemistry , Receptors, Purinergic P2X7/genetics , Receptors, Purinergic P2X7/metabolism , Transcriptional Activation
3.
Proc Natl Acad Sci U S A ; 119(6)2022 02 08.
Article En | MEDLINE | ID: mdl-35131851

For an efficacious vaccine immunogen, influenza hemagglutinin (HA) needs to maintain a stable quaternary structure, which is contrary to the inherently dynamic and metastable nature of class I fusion proteins. In this study, we stabilized HA with three substitutions within its pH-sensitive regions where the refolding starts. An X-ray structure reveals how these substitutions stabilize the intersubunit ß-sheet in the base and form an interprotomeric aliphatic layer across the stem while the native prefusion HA fold is retained. The identification of the stabilizing substitutions increases our understanding of how the pH sensitivity is structurally accomplished in HA and possibly other pH-sensitive class I fusion proteins. Our stabilization approach in combination with the occasional back mutation of rare amino acids to consensus results in well-expressing stable trimeric HAs. This repair and stabilization approach, which proves broadly applicable to all tested influenza A HAs of group 1 and 2, will improve the developability of influenza vaccines based on different types of platforms and formats and can potentially improve efficacy.


Hemagglutinin Glycoproteins, Influenza Virus/genetics , Hemagglutinins/genetics , Amino Acids/genetics , Cell Line , Humans , Hydrogen-Ion Concentration , Influenza Vaccines/genetics , Influenza, Human/virology , Mutation/genetics , Protein Conformation, beta-Strand/genetics
4.
Int J Mol Sci ; 22(22)2021 Nov 19.
Article En | MEDLINE | ID: mdl-34830391

Parkinson's disease (PD) is the second most common neurodegenerative disorder. An important hallmark of PD involves the pathological aggregation of proteins in structures known as Lewy bodies. The major component of these proteinaceous inclusions is alpha (α)-synuclein. In different conditions, α-synuclein can assume conformations rich in either α-helix or ß-sheets. The mechanisms of α-synuclein misfolding, aggregation, and fibrillation remain unknown, but it is thought that ß-sheet conformation of α-synuclein is responsible for its associated toxic mechanisms. To gain fundamental insights into the process of α-synuclein misfolding and aggregation, the secondary structure of this protein in the presence of charged and non-charged surfactant solutions was characterized. The selected surfactants were (anionic) sodium dodecyl sulphate (SDS), (cationic) cetyltrimethylammonium chloride (CTAC), and (uncharged) octyl ß-D-glucopyranoside (OG). The effect of surfactants in α-synuclein misfolding was assessed by ultra-structural analyses, in vitro aggregation assays, and secondary structure analyses. The α-synuclein aggregation in the presence of negatively charged SDS suggests that SDS-monomer complexes stimulate the aggregation process. A reduction in the electrostatic repulsion between N- and C-terminal and in the hydrophobic interactions between the NAC (non-amyloid beta component) region and the C-terminal seems to be important to undergo aggregation. Fourier transform infrared spectroscopy (FTIR) measurements show that ß-sheet structures comprise the assembly of the fibrils.


Neurodegenerative Diseases/drug therapy , Parkinson Disease/drug therapy , Protein Aggregation, Pathological/drug therapy , alpha-Synuclein/genetics , Amyloid/antagonists & inhibitors , Amyloid/genetics , Cetrimonium/pharmacology , Circular Dichroism , Galactosides/pharmacology , Humans , Lewy Bodies/drug effects , Lewy Bodies/ultrastructure , Neurodegenerative Diseases/pathology , Parkinson Disease/genetics , Parkinson Disease/pathology , Protein Aggregation, Pathological/genetics , Protein Aggregation, Pathological/pathology , Protein Conformation , Protein Conformation, beta-Strand/genetics , Protein Folding/drug effects , Protein Structure, Secondary/drug effects , Sodium Dodecyl Sulfate/pharmacology , Spectroscopy, Fourier Transform Infrared , alpha-Synuclein/antagonists & inhibitors
5.
Sci Rep ; 11(1): 20887, 2021 10 22.
Article En | MEDLINE | ID: mdl-34686701

Rapid and sensitive detection of Salmonella is a critical step in routine food quality control, outbreak investigation, and food recalls. Although various genes have been the targets in the design of rapid molecular detection methods for Salmonella, there is limited information on the diversity of these target genes at the level of DNA sequence and the encoded protein structures. In this study, we investigated the diversity of ten target genes (invA, fimA, phoP, spvC, and agfA; ttrRSBCA operon including 5 genes) commonly used in the detection and identification of Salmonella. To this end, we performed whole genome sequencing of 143 isolates of Salmonella serotypes (Enteritidis, Typhimurium, and Heidelberg) obtained from poultry (eggs and chicken). Phylogenetic analysis showed that Salmonella ser. Typhimurium was more diverse than either Enteritidis or Heidelberg. Forty-five non-synonymous mutations were identified in the target genes from the 143 isolates, with the two most common mutations as T ↔ C (15 times) and A ↔ G (13 times). The gene spvC was primarily present in Salmonella ser. Enteritidis isolates and absent from Heidelberg isolates, whereas ttrR was more conserved (0 non-synonymous mutations) than ttrS, ttrB, ttrC, and ttrA (7, 2, 2, and 7 non-synonymous mutations, respectively). Notably, we found one non-synonymous mutation (fimA-Mut.6) across all Salmonella ser. Enteritidis and Salmonella ser. Heidelberg, C → T (496 nt postion), resulting in the change at AA 166 position, Glutamine (Q) → Stop condon (TAG), suggesting that the fimA gene has questionable sites as a target for detection. Using Phyre2 and SWISS-MODEL software, we predicted the structures of the proteins encoded by some of the target genes, illustrating the positions of these non-synonymous mutations that mainly located on the α-helix and ß-sheet which are key elements for maintaining the conformation of proteins. These results will facilitate the development of sensitive molecular detection methods for Salmonella.


Proteins/genetics , Salmonella enteritidis/genetics , Animals , Codon, Terminator/genetics , Mutation/genetics , Operon/genetics , Phylogeny , Poultry/microbiology , Protein Conformation, alpha-Helical/genetics , Protein Conformation, beta-Strand/genetics , Serogroup , Whole Genome Sequencing/methods
6.
Biochim Biophys Acta Mol Basis Dis ; 1867(12): 166234, 2021 12 01.
Article En | MEDLINE | ID: mdl-34339840

TAR DNA-binding protein-43 (TDP-43) pathology, including fibrillar aggregates and mutations, develops in amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration (FTLD) and limbic-predominant age-related TDP-43 encephalopathy (LATE). Hyperphosphorylation and aggregation of TDP-43 contribute to pathology and are viable therapeutic targets for ALS. In vivo inhibition of TDP-43 aggregation was evaluated using anti-TDP-43 antibodies with promising outcomes. However, the exact mechanism of antibody-based inhibition targeting TDP-43 is not well understood but may lead to the identification of viable immunotherapies. Herein, the mechanism of in vitro aggregation of phosphorylated TDP-43 was explored, and the anti-TDP-43 antibodies tested for their inhibitor efficacies. Specifically, the aggregation of phosphorylated full-length TDP-43 protein (pS410) was monitored by transmission electron microscopy (TEM), turbidity absorbance, and thioflavin (ThT) spectroscopy. The protein aggregates were insoluble, ThT-positive and characterized with heterogeneous morphologies (fibers, amorphous structures). Antibodies specific to epitopes 178-393 and 256-269, within the RRM2-CTD domain, reduced the formation of ß-sheets and insoluble aggregates, at low antibody loading (antibody: protein ratio = 1 µg/mL: 45 µg/mL). Inhibition outcomes were highly dependent on the type and loading of antibodies, indicating dual functionality of such inhibitors, as aggregation inhibitors or aggregation promoters. Anti-SOD1 and anti-tau antibodies were not effective inhibitors against TDP-43 aggregation, indicating selective inhibition.


Amyotrophic Lateral Sclerosis/genetics , Antibodies, Anti-Idiotypic/immunology , Brain Diseases/genetics , DNA-Binding Proteins/genetics , Frontotemporal Lobar Degeneration/genetics , Amyotrophic Lateral Sclerosis/immunology , Amyotrophic Lateral Sclerosis/pathology , Amyotrophic Lateral Sclerosis/therapy , Brain Diseases/immunology , Brain Diseases/pathology , Brain Diseases/therapy , DNA-Binding Proteins/antagonists & inhibitors , DNA-Binding Proteins/immunology , Epitopes/immunology , Frontotemporal Lobar Degeneration/immunology , Frontotemporal Lobar Degeneration/pathology , Frontotemporal Lobar Degeneration/therapy , Humans , Microscopy, Electron, Transmission , Phosphorylation/genetics , Protein Aggregates/genetics , Protein Aggregates/immunology , Protein Aggregation, Pathological/genetics , Protein Aggregation, Pathological/immunology , Protein Aggregation, Pathological/pathology , Protein Aggregation, Pathological/therapy , Protein Conformation, beta-Strand/genetics , Superoxide Dismutase-1/antagonists & inhibitors , Superoxide Dismutase-1/immunology , tau Proteins/antagonists & inhibitors , tau Proteins/immunology
7.
Nat Commun ; 12(1): 2987, 2021 05 20.
Article En | MEDLINE | ID: mdl-34016967

The elongasome, or Rod system, is a protein complex that controls cell wall formation in rod-shaped bacteria. MreC is a membrane-associated elongasome component that co-localizes with the cytoskeletal element MreB and regulates the activity of cell wall biosynthesis enzymes, in a process that may be dependent on MreC self-association. Here, we use electron cryo-microscopy and X-ray crystallography to determine the structure of a self-associated form of MreC from Pseudomonas aeruginosa in atomic detail. MreC monomers interact in head-to-tail fashion. Longitudinal and lateral interfaces are essential for oligomerization in vitro, and a phylogenetic analysis of proteobacterial MreC sequences indicates the prevalence of the identified interfaces. Our results are consistent with a model where MreC's ability to alternate between self-association and interaction with the cell wall biosynthesis machinery plays a key role in the regulation of elongasome activity.


Bacterial Proteins/metabolism , Cell Wall/metabolism , Pseudomonas aeruginosa/metabolism , Amino Acid Sequence/genetics , Bacterial Proteins/genetics , Bacterial Proteins/isolation & purification , Bacterial Proteins/ultrastructure , Cell Wall/ultrastructure , Conserved Sequence/genetics , Cryoelectron Microscopy , Crystallography, X-Ray , Mutagenesis , Phylogeny , Protein Conformation, alpha-Helical/genetics , Protein Conformation, beta-Strand/genetics , Protein Domains/genetics , Protein Multimerization , Pseudomonas aeruginosa/cytology , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/ultrastructure , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Recombinant Proteins/ultrastructure
8.
Molecules ; 26(4)2021 Feb 11.
Article En | MEDLINE | ID: mdl-33670093

The misfolding and aggregation of polypeptide chains into ß-sheet-rich amyloid fibrils is associated with a wide range of neurodegenerative diseases. Growing evidence indicates that the oligomeric intermediates populated in the early stages of amyloid formation rather than the mature fibrils are responsible for the cytotoxicity and pathology and are potentially therapeutic targets. However, due to the low-populated, transient, and heterogeneous nature of amyloid oligomers, they are hard to characterize by conventional bulk methods. The development of single molecule approaches provides a powerful toolkit for investigating these oligomeric intermediates as well as the complex process of amyloid aggregation at molecular resolution. In this review, we present an overview of recent progress in characterizing the oligomerization of amyloid proteins by single molecule fluorescence techniques, including single-molecule Förster resonance energy transfer (smFRET), fluorescence correlation spectroscopy (FCS), single-molecule photobleaching and super-resolution optical imaging. We discuss how these techniques have been applied to investigate the different aspects of amyloid oligomers and facilitate understanding of the mechanism of amyloid aggregation.


Amyloid beta-Peptides/chemistry , Amyloid/chemistry , Amyloidogenic Proteins/chemistry , Protein Aggregation, Pathological/genetics , Amyloid beta-Peptides/genetics , Amyloid beta-Peptides/ultrastructure , Amyloidogenic Proteins/genetics , Amyloidogenic Proteins/ultrastructure , Fluorescence Resonance Energy Transfer , Humans , Kinetics , Protein Conformation, beta-Strand/genetics , Single Molecule Imaging , Spectrometry, Fluorescence
9.
Int J Mol Sci ; 22(3)2021 Jan 27.
Article En | MEDLINE | ID: mdl-33513895

We designed three types of RGD-containing barnacle adhesive proteins using self-assembling peptides. In the present study, three types of RGD-containing peptides were synthesized by solid-phase peptide synthesis, and the secondary structures of these peptides were analyzed by CD and FT-IR spectroscopy. The mechanical properties of peptide hydrogels were characterized by a rheometer. We discuss the correlation between the peptide conformation, and cell attachment and cell spreading activity from the viewpoint of developing effective tissue engineering scaffolds. We created a peptide-coated cell culture substrate by coating peptides on a polystyrene plate. They significantly facilitated cell adhesion and spreading compared to a non-coated substrate. When the RGDS sequence was modified at N- or C-terminal of R-Y, it was found that the self-assembling ability was dependent on the strongly affects hydrogel formation and cell adhesion caused by its secondary structure.


Immobilized Proteins/chemistry , Peptides/chemistry , Protein Conformation, beta-Strand/genetics , Proteins/chemistry , Animals , Immobilized Proteins/genetics , Immobilized Proteins/ultrastructure , Peptides/genetics , Proteins/ultrastructure , Thoracica/chemistry , Thoracica/genetics
10.
Int J Mol Sci ; 22(3)2021 Jan 27.
Article En | MEDLINE | ID: mdl-33513738

The amyloid-ß (Aß) peptides are associated with two prominent diseases in the brain, Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA). Aß42 is the dominant component of cored parenchymal plaques associated with AD, while Aß40 is the predominant component of vascular amyloid associated with CAA. There are familial CAA mutations at positions Glu22 and Asp23 that lead to aggressive Aß aggregation, drive vascular amyloid deposition and result in degradation of vascular membranes. In this study, we compared the transition of the monomeric Aß40-WT peptide into soluble oligomers and fibrils with the corresponding transitions of the Aß40-Dutch (E22Q), Aß40-Iowa (D23N) and Aß40-Dutch, Iowa (E22Q, D23N) mutants. FTIR measurements show that in a fashion similar to Aß40-WT, the familial CAA mutants form transient intermediates with anti-parallel ß-structure. This structure appears before the formation of cross-ß-sheet fibrils as determined by thioflavin T fluorescence and circular dichroism spectroscopy and occurs when AFM images reveal the presence of soluble oligomers and protofibrils. Although the anti-parallel ß-hairpin is a common intermediate on the pathway to Aß fibrils for the four peptides studied, the rate of conversion to cross-ß-sheet fibril structure differs for each.


Alzheimer Disease/metabolism , Amyloid beta-Peptides/chemistry , Amyloid/chemistry , Cerebral Amyloid Angiopathy/genetics , Amyloid/metabolism , Amyloid beta-Peptides/genetics , Amyloid beta-Peptides/metabolism , Benzothiazoles , Cerebral Amyloid Angiopathy/metabolism , Circular Dichroism , Fluorescence , Microscopy, Atomic Force , Mutation , Plaque, Amyloid/genetics , Plaque, Amyloid/metabolism , Protein Conformation, beta-Strand/genetics , Spectroscopy, Fourier Transform Infrared
11.
Curr Opin Genet Dev ; 67: 111-118, 2021 04.
Article En | MEDLINE | ID: mdl-33454579

Eukaryotic cells express thousands of protein domains long believed to function in the absence of molecular order. These intrinsically disordered protein (IDP) domains are typified by gibberish-like repeats of only a limited number of amino acids that we refer to as domains of low sequence complexity. A decade ago, it was observed that these low complexity (LC) domains can undergo phase transition out of aqueous solution to form either liquid-like droplets or hydrogels. The self-associative interactions responsible for phase transition involve the formation of specific cross-ß structures that are unusual in being labile to dissociation. Here we give evidence that the LC domains of two RNA binding proteins, ataxin-2 and TDP43, form cross-ß interactions that specify biologically relevant redox sensors.


Ataxin-2/genetics , DNA-Binding Proteins/genetics , Protein Domains/genetics , RNA-Binding Proteins/genetics , Amino Acid Sequence/genetics , Eukaryotic Cells/metabolism , Eukaryotic Cells/ultrastructure , Gene Expression Regulation/genetics , Intrinsically Disordered Proteins/genetics , Intrinsically Disordered Proteins/ultrastructure , Oxidation-Reduction , Protein Conformation, beta-Strand/genetics
12.
Biochim Biophys Acta Mol Basis Dis ; 1867(2): 166018, 2021 02 01.
Article En | MEDLINE | ID: mdl-33246011

Studies have established that congenital cataract is the major cause of blindness in children across the globe. The ß-crystallin protein family is the richest and most soluble structural protein in the lens. Their solubility and stability are essential in maintaining lens transparency. In this study, we identified a novel ßB2 mutation W151R in a rare progressive cortical congenital cataract family and explored its pathogenesis using purified protein and mutant related cataract-cell models. Due to its low solubility and poor structural stability, the ßB2 W151R mutation was prone to aggregation. Moreover, the W151R mutation enhanced the exposure of the hydrophobic side chains in the fourth Greek Key motif, which were readily degraded by trypsin. However, upon the administration of lanosterol, the negative effect of the W151R mutation was reversed. Therefore, lanosterol is a potential therapeutic option for cataracts.


Cataract/congenital , Lanosterol/therapeutic use , Lens, Crystalline/pathology , Protein Aggregation, Pathological/genetics , beta-Crystallin B Chain/genetics , Cataract/drug therapy , Cataract/genetics , Cataract/pathology , Child, Preschool , DNA Mutational Analysis , Female , HEK293 Cells , HeLa Cells , Humans , Hydrophobic and Hydrophilic Interactions/drug effects , Lanosterol/pharmacology , Lens, Crystalline/drug effects , Male , Molecular Dynamics Simulation , Mutagenesis, Site-Directed , Mutation , Pedigree , Protein Aggregation, Pathological/congenital , Protein Aggregation, Pathological/drug therapy , Protein Conformation, beta-Strand/drug effects , Protein Conformation, beta-Strand/genetics , Proteolysis/drug effects , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Trypsin/metabolism , beta-Crystallin B Chain/chemistry , beta-Crystallin B Chain/isolation & purification , beta-Crystallin B Chain/metabolism
13.
FEBS J ; 288(18): 5300-5310, 2021 09.
Article En | MEDLINE | ID: mdl-33305524

The translocase of the outer mitochondrial membrane (TOM) complex is the main entry gate for most mitochondrial proteins. The TOM complex is a multisubunit membrane protein complex consisting of a ß-barrel protein Tom40 and six α-helical transmembrane (TM) proteins, receptor subunits Tom20, Tom22, and Tom70, and regulatory subunits Tom5, Tom6, and Tom7. Although nearly 30 years have passed since the main components of the TOM complex were identified and characterized, the structural details of the TOM complex remained poorly understood until recently. Thanks to the rapid development of the cryoelectron microscopy (EM) technology, high-resolution structures of the yeast TOM complex have become available. The identified structures showed a symmetric dimer containing five different subunits including Tom22. Biochemical and mutational analyses based on the TOM complex structure revealed the presence of different translocation paths within the Tom40 import channel for different classes of translocating precursor proteins. Previous studies including our cross-linking analyses indicated that the TOM complex in intact mitochondria is present as a mixture of the trimeric complex containing Tom22. Furthermore, the dimeric complex lacking Tom22, and the trimer and dimer may handle different sets of mitochondrial precursor proteins for translocation across the outer membrane. In this Structural Snapshot, we will discuss possible rearrangement of the subunit interactions upon dynamic conversion of the TOM complex between the different subunit assembly states, the Tom22-containing core dimer and trimer.


Carrier Proteins/ultrastructure , Mitochondrial Membrane Transport Proteins/ultrastructure , Protein Conformation , Saccharomyces cerevisiae Proteins/ultrastructure , Carrier Proteins/genetics , Mitochondria/genetics , Mitochondria/ultrastructure , Mitochondrial Membrane Transport Proteins/genetics , Mitochondrial Precursor Protein Import Complex Proteins , Mitochondrial Proteins/genetics , Mitochondrial Proteins/ultrastructure , Multiprotein Complexes/genetics , Multiprotein Complexes/ultrastructure , Protein Conformation, alpha-Helical , Protein Conformation, beta-Strand/genetics , Protein Transport/genetics , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/ultrastructure , Saccharomyces cerevisiae Proteins/genetics
14.
J Struct Biol ; 212(2): 107614, 2020 11 01.
Article En | MEDLINE | ID: mdl-32911070

Hedgehog signaling plays a crucial role in embryogenesis and adult tissue homeostasis, and mutations of its key components such as Suppressor of fused (Sufu) are closely associated with human diseases. The Ser/Thr kinase Fused (Fu) promotes Hedgehog signaling by phosphorylating the Cubitus interruptus (Ci)/Glioma-associated oncogene homologue (Gli) family of transcription factors. Sufu associates with both Fu and Ci/Gli, but the recognition mechanism between Sufu and Fu remains obscure. Here, our structure of the N-terminal domain (NTD) of Drosophila Sufu (dSufu) in complex with the Sufu-binding site (SBS) of Fu reveals that both main-chain ß sheet formation and side-chain hydrophobic interactions contribute to the recognition between Sufu and Fu, and point mutations of highly conserved interface residues eliminated their association. Structural comparison suggests that Fu and Ci/Gli bind on opposite sides of dSufu-NTD, allowing the formation of a Fu-dSufu-Ci ternary complex which facilitates the phosphorylation of Ci/Gli by Fu. Hence, our results provide insights into the Sufu-Fu recognition mechanism.


Drosophila Proteins/genetics , Hedgehog Proteins/genetics , Repressor Proteins/genetics , Signal Transduction/genetics , Animals , DNA-Binding Proteins/genetics , Drosophila/genetics , Protein Binding/genetics , Protein Conformation, beta-Strand/genetics , Protein Serine-Threonine Kinases/genetics
15.
Nat Commun ; 11(1): 4141, 2020 08 18.
Article En | MEDLINE | ID: mdl-32811830

Members of the Herpesviridae, including the medically important alphaherpesvirus varicella-zoster virus (VZV), induce fusion of the virion envelope with cell membranes during entry, and between cells to form polykaryocytes in infected tissues. The conserved glycoproteins, gB, gH and gL, are the core functional proteins of the herpesvirus fusion complex. gB serves as the primary fusogen via its fusion loops, but functions for the remaining gB domains remain unexplained. As a pathway for biological discovery of domain function, our approach used structure-based analysis of the viral fusogen together with a neutralizing antibody. We report here a 2.8 Å cryogenic-electron microscopy structure of native gB recovered from VZV-infected cells, in complex with a human monoclonal antibody, 93k. This high-resolution structure guided targeted mutagenesis at the gB-93k interface, providing compelling evidence that a domain spatially distant from the gB fusion loops is critical for herpesvirus fusion, revealing a potential new target for antiviral therapies.


Antibodies, Neutralizing/chemistry , Herpesvirus 3, Human/chemistry , Viral Envelope Proteins/chemistry , Virus Internalization , Antibodies, Neutralizing/immunology , Antibodies, Neutralizing/ultrastructure , Cryoelectron Microscopy , Humans , Hydrophobic and Hydrophilic Interactions , Models, Molecular , Protein Conformation, beta-Strand/genetics , Protein Domains/genetics , Viral Envelope Proteins/immunology , Viral Envelope Proteins/ultrastructure
16.
Commun Biol ; 3(1): 402, 2020 07 29.
Article En | MEDLINE | ID: mdl-32728168

Prion diseases, a group of incurable, lethal neurodegenerative disorders of mammals including humans, are caused by prions, assemblies of misfolded host prion protein (PrP). A single point mutation (G127V) in human PrP prevents prion disease, however the structural basis for its protective effect remains unknown. Here we show that the mutation alters and constrains the PrP backbone conformation preceding the PrP ß-sheet, stabilising PrP dimer interactions by increasing intermolecular hydrogen bonding. It also markedly changes the solution dynamics of the ß2-α2 loop, a region of PrP structure implicated in prion transmission and cross-species susceptibility. Both of these structural changes may affect access to protein conformers susceptible to prion formation and explain its profound effect on prion disease.


Prion Diseases/genetics , Prion Proteins/genetics , Prions/genetics , Protein Conformation , Animals , Humans , Point Mutation/genetics , Prion Diseases/pathology , Prion Proteins/ultrastructure , Prions/ultrastructure , Protein Conformation, beta-Strand/genetics
17.
Open Biol ; 10(7): 200004, 2020 07.
Article En | MEDLINE | ID: mdl-32692959

Anti-cancer peptides (ACPs) are a series of short peptides composed of 10-60 amino acids that can inhibit tumour cell proliferation or migration, or suppress the formation of tumour blood vessels, and are less likely to cause drug resistance. The aforementioned merits make ACPs the most promising anti-cancer candidate. However, ACPs may be degraded by proteases, or result in cytotoxicity in many cases. To overcome these drawbacks, a plethora of research has focused on reconstruction or modification of ACPs to improve their anti-cancer activity, while reducing their cytotoxicity. The modification of ACPs mainly includes main chain reconstruction and side chain modification. After summarizing the classification and mechanism of action of ACPs, this paper focuses on recent development and progress about their reconstruction and modification. The information collected here may provide some ideas for further research on ACPs, in particular their modification.


Antineoplastic Agents/therapeutic use , Neoplasms/drug therapy , Neovascularization, Pathologic/drug therapy , Peptides/therapeutic use , Apoptosis/drug effects , Apoptosis/genetics , Humans , Neoplasms/genetics , Neoplasms/pathology , Neovascularization, Pathologic/genetics , Neovascularization, Pathologic/pathology , Peptides/classification , Peptides/genetics , Protein Conformation, alpha-Helical/genetics , Protein Conformation, beta-Strand/genetics
18.
Nat Commun ; 11(1): 3146, 2020 06 19.
Article En | MEDLINE | ID: mdl-32561718

Phosphorylation of intrinsically disordered eIF4E binding proteins (4E-BPs) regulates cap-dependent translation by weakening their ability to compete with eIF4G for eIF4E binding within the translation initiation complex. We previously showed that phosphorylation of T37 and T46 in 4E-BP2 induces folding of a four-stranded beta-fold domain, partially sequestering the canonical eIF4E-binding helix. The C-terminal intrinsically disordered region (C-IDR), remaining disordered after phosphorylation, contains the secondary eIF4E-binding site and three other phospho-sites, whose mechanisms in inhibiting binding are not understood. Here we report that the domain is non-cooperatively folded, with exchange between beta strands and helical conformations. C-IDR phosphorylation shifts the conformational equilibrium, controlling access to eIF4E binding sites. The hairpin turns formed by pT37/pT46 are remarkably stable and function as transplantable units for phospho-regulation of stability. These results demonstrate how non-cooperative folding and conformational exchange leads to graded inhibition of 4E-BP2:eIF4E binding, shifting 4E-BP2 into an eIF4E binding-incompatible conformation and regulating translation initiation.


Eukaryotic Initiation Factor-4E/metabolism , Intrinsically Disordered Proteins/metabolism , Protein Biosynthesis/physiology , RNA Caps/metabolism , Computational Biology , Eukaryotic Initiation Factor-4E/genetics , Intrinsically Disordered Proteins/genetics , Mutagenesis, Site-Directed , Nuclear Magnetic Resonance, Biomolecular , Phosphorylation/physiology , Protein Binding/genetics , Protein Conformation, alpha-Helical/genetics , Protein Conformation, beta-Strand/genetics , Protein Folding , Protein Processing, Post-Translational/physiology
19.
FEBS Open Bio ; 10(6): 1180-1189, 2020 06.
Article En | MEDLINE | ID: mdl-32359208

Xylanase B, a member of subfamily 7 of the GH30 (glycoside hydrolase family 30) from Talaromyces cellulolyticus (TcXyn30B), is a bifunctional enzyme with glucuronoxylanase and xylobiohydrolase activities. In the present study, crystal structures of the native enzyme and the enzyme-product complex of TcXyn30B expressed in Pichia pastoris were determined at resolutions of 1.60 and 1.65 Å, respectively. The enzyme complexed with 22 -(4-O-methyl-α-d-glucuronyl)-xylobiose (U4m2 X) revealed that TcXyn30B strictly recognizes both the C-6 carboxyl group and the 4-O-methyl group of the 4-O-methyl-α-d-glucuronyl side chain by the conserved residues in GH30-7 endoxylanases. The crystal structure and site-directed mutagenesis indicated that Asn-93 on the ß2-α2-loop interacts with the non-reducing end of the xylose residue at subsite-2 and is likely to be involved in xylobiohydrolase activity. These findings provide structural insight into the mechanisms of substrate recognition of GH30-7 glucuronoxylanase and xylobiohydrolase.


Endo-1,4-beta Xylanases/metabolism , Talaromyces/enzymology , Xylans/metabolism , Amino Acid Sequence/genetics , Crystallography, X-Ray , Endo-1,4-beta Xylanases/genetics , Endo-1,4-beta Xylanases/isolation & purification , Endo-1,4-beta Xylanases/ultrastructure , Models, Molecular , Mutagenesis, Site-Directed , Protein Conformation, alpha-Helical/genetics , Protein Conformation, beta-Strand/genetics , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Recombinant Proteins/ultrastructure , Saccharomycetales , Sequence Alignment , Substrate Specificity
20.
Sci Rep ; 10(1): 7721, 2020 05 07.
Article En | MEDLINE | ID: mdl-32382058

Amyloids are protein aggregates observed in several diseases, for example in Alzheimer's and Parkinson's diseases. An aggregate has a very regular beta structure with a tightly packed core, which spontaneously assumes a steric zipper form. Experimental methods enable studying such peptides, however they are tedious and costly, therefore inappropriate for genomewide studies. Several bioinformatic methods have been proposed to evaluate protein propensity to form an amyloid. However, the knowledge of aggregate structures is usually not taken into account. We propose PATH (Prediction of Amyloidogenicity by THreading) - a novel structure-based method for predicting amyloidogenicity and show that involving available structures of amyloidogenic fragments enhances classification performance. Experimental aggregate structures were used in templatebased modeling to recognize the most stable representative structural class of a query peptide. Several machine learning methods were then applied on the structural models, using their energy terms. Finally, we identified the most important terms in classification of amyloidogenic peptides. The proposed method outperforms most of the currently available methods for predicting amyloidogenicity, with its area under ROC curve equal to 0.876. Furthermore, the method gave insight into significance of selected structural features and the potentially most stable structural class of a peptide fragment if subjected to crystallization.


Amyloid/ultrastructure , Peptide Fragments/ultrastructure , Protein Conformation, beta-Strand/genetics , Software , Algorithms , Alzheimer Disease/genetics , Alzheimer Disease/pathology , Amyloid/chemistry , Computational Biology/methods , Humans , Parkinson Disease/genetics , Parkinson Disease/pathology , Peptide Fragments/chemistry , Protein Aggregates/genetics , Protein Aggregation, Pathological/genetics , Protein Aggregation, Pathological/pathology
...